Second primary tumor in anti-Ma1/2-positive paraneoplastic limbic encephalitis

Journal of Neuro-Oncology

Volumn 78, Issue 1, 2006, Pages 49-51

  Leyhe, Thomas ^a   Schule R ^b   Schwarzler F ^a   Gasser, T ^b   Haarmeier, T ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adenocarcinoma of the cecum; Carcinoma of the prostate; Dementia; Paraneoplastic limbic encephalitis

Indexed keywords

CHOLINESTERASE INHIBITOR; FLUORODEOXYGLUCOSE F 18; MA1 ANTIBODY; MA2 ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ANOREXIA; ARTICLE; CASE REPORT; CECUM CARCINOMA; CLINICAL FEATURE; COGNITIVE DEFECT; COLONOSCOPY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; FOLLOW UP; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PROSTATE CARCINOMA; PROSTATECTOMY; SECOND CANCER; SHORT TERM MEMORY; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT REDUCTION; WESTERN BLOTTING; WHOLE BODY SCINTISCANNING;

EID: 33646857650     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9052-6     Document Type: Article

References (16)

1. Voltz R, 2002 Paraneoplastic neurological syndromes: An update on diagnosis pathogenesis, and therapy Lancet Neurol 1: 294-305
2. Graus F, Delattre JY, Antoine JC, et al. 2004 Recommended diagnostic criteria for paraneoplastic neurological syndromes J Neurol Neurosurg Psychiatry 75: 1135-1140
3. Gultekin SH, Rosenfeld MR, Votz R, et al. 2000 Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients Brain 123: 1481-1494
4. Hulstaert F, Blennow K, Ivanoiu A, et al., 1999 Improved discrimination of AD patients using beta-amyloid 1-42 and tau levels in CSF Neurology 52: 1555-1562
5. Saiz A, Graus F, Dalmau J, et al. 1999 Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders Ann Neurol 46: 774-777
6. Modrego PJ, Cay A, Pina MA, Monge A, 2002 Paraneoplastic subacute encephalitis caused by adenocarcinoma of prostate: A clinico-pathological case report Acta Neurol Scand 105: 351-353
7. Graus F, Keime-Guibert F, Ramon R, et al. 2001 Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients Brain 124: 1138-1148
8. Stern RC, Hulette CM, 1999 Paraneoplastic limbic encephalitis associated with small cell carcinoma of the prostate Mod Pathol 12 (8): 814-818
9. Dalmau J, Gultekin H, Voltz R, et al. 1999 Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders Brain 122: 27-39
10. Rosenfeld MR, Eichen JG, Deborky FW, et al. 2001 Molecular and clinical diversity in paraneoplastic immunity to Ma proteins Ann Neurol 50: 339-348
11. Dalmau J, Graus F, Villarejo A, et al. 2004 Clinical analysis of anti-Ma2-associated encephalitis Brain 127: 1831-1844
12. Voltz R, Gultekin H, Rosenfeld MR, et al. 1999 A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer N Engl J Med 340: 1788-1795
13. Linke R, Schroeder M, Helmberger T, Voltz R, 2004 Antibody-positive paraneoplastic neurologic syndromes. Value of CT and PET for tumor diagnosis Neurology 63: 282-286
14. Rees JH, Hain SF, Johnson MR, et al. 2001 The role of (18 F)fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders Brain 124: 2223-2231
15. Antoine JC, Cinotti L, Tilikete C, et al. 2000 (18 F)Fluorodeoxyglucose Positron Emission Tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies Ann Neurol 48: 105-108
16. Younes-Mhenni S, Janier MF, Cinotti L, et al. 2004 FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes Brain 127: 2331-2338